Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors

The purpose of this study was to retrospectively review the pathologic complete response (pCR) rate from patients (n=86) with stage II and III HER2-positive breast cancer treated with neoadjuvant chemotherapy at our institution from 2008 to 2013 and to determine possible predictive and prognostic fa...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: I.P.C. Buzatto, A. Ribeiro-Silva, J.M. Andrade, H.H.A. Carrara, W.A. Silveira, D.G. Tiezzi
Format: Artigo
Langue:Inglês
Publié: Associação Brasileira de Divulgação Científica
Collection:Brazilian Journal of Medical and Biological Research
Sujets:
Neoadjuvant chemotherapy
Trastuzumab
Pathologic complete response
Predictive factors of response
Prognosis
Accès en ligne:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000200702&lng=en&tlng=en
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires